FDA approves new inhaled insulin Afrezza

FDA - The U.S. Food and Drug Administration approved a new form of insulin that can be inhaled rather than injected. Called Afrezza, the drug is a dry powder that diabetes patients can breathe in using an insul...
article placeholder

FDA approves antibacterial agent Dalvance

The FDA has recently approved the antibacterial agent dalbavancin (Dalvance) for treatment of adult skin infections. Dalvance, marketed by the Chicago-based Durata Therapeutics,  is meant to treat acute bact...